Advanced and Metastatic Breast Cancer |
1 |
1 |
Otolaryngology |
0 |
0.97 |
Dentistry and Oral Health |
0 |
0.84 |
Breast Cancer |
0 |
0.83 |
Toxicology |
0 |
0.62 |
Cancer |
0 |
0.58 |
Chemotherapy |
0 |
0.49 |
Targeted Cancer Therapy |
0 |
0.48 |
Biologic Therapy |
0 |
0.47 |
Genomic Medicine |
0 |
0.43 |
Breast |
0 |
0.39 |
Quality of Life |
0 |
0.26 |
Epidermal Growth Factor Receptor |
0 |
0.21 |
Selective Estrogen Receptor Modulators |
0 |
0.21 |
Diarrhea |
0 |
0.19 |
Hyperglycemia |
0 |
0.19 |
Pain |
0 |
0.19 |
Pain Management |
0 |
0.19 |
Receptors |
0 |
0.19 |
Aromatase Inhibitors |
0 |
0.1 |
Endocrine Therapy |
0 |
0.1 |
Experimental Drug |
0 |
0.1 |
Food and Drug Administration (FDA) |
0 |
0.1 |
Grant |
0 |
0.1 |
Hospital |
0 |
0.1 |
Massachusetts |
0 |
0.1 |
Preventive Oral Hygiene |
0 |
0.1 |
Steroids |
0 |
0.1 |